Saturday 17 October 2026
Export KRRO’s income statement to Excel — free account
Korro Bio, Inc.
KRRO Healthcare Biotechnology
Korro Bio, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $6.4 million, up 181.5% from fiscal 2024. In the quarter to June 2026, revenue fell 86.3%, EPS grew 61.0% and free cash flow grew 12.1%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
8.53
0.78
−8.38%
Follow KRRO
| Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | — | 2 | — | — | — | — |
P/E ratio |
— | — | 0.00 | 0.00 | 0.00 | — | — | 0.00 | 0.00 |
P/S ratio |
— | — | 0.00 | 30.75 | 5.00 | — | — | 9.63 | 11.77 |
Altman Z-Score |
— | — | 1.93 | 9.64 | (0.04) | — | — | 0.73 | (6.75) |
P/FCF ratio |
— | — | 4.57 | 0.00 | 0.00 | — | — | 0.00 | 0.00 |
Altman Z″-Score (non-manufacturers) |
— | — | 6.47 | 5.84 | 0.67 | — | — | (0.63) | (13.30) |
P/Operating CF |
— | — | (5.10) | (76.67) | (9.85) | — | — | (45.31) | (4.25) |
Beneish M-Score |
— | — | — | 106.45 | (3.22) | — | — | — | (3.49) |
P/B ratio |
— | — | 0.91 | 5.91 | 1.35 | — | — | 2.12 | 1.46 |
Price to Tangible BV |
— | — | 0.91 | 5.91 | 1.35 | — | — | 2.12 | 1.46 |
EV/Sales |
— | — | 0.00 | 25.21 | 1.72 | — | — | 6.57 | 2.88 |
EV/EBITDA |
— | — | 3.31 | 0.00 | 0.00 | — | — | 0.00 | 0.00 |
EV/Operating CF |
— | — | (1.92) | (20.63) | (0.80) | — | — | (3.86) | (0.23) |
EV/FCF |
— | — | (1.98) | (17.98) | (0.77) | — | — | (2.97) | (0.23) |
Quick Ratio |
8.06 | 11.22 | 4.13 | 8.29 | 11.45 | 6.40 | 8.53 | 8.54 | 6.38 |
Current Ratio |
8.07 | 11.38 | 4.19 | 8.45 | 11.79 | 6.56 | 8.87 | 8.79 | 6.90 |
Net Debt/EBITDA |
(1.82) | (2.34) | 10.94 | 7.76 | 1.42 | 0.98 | 2.05 | 1.40 | 0.64 |
Debt/Assets |
0.00% | 190.66% | 0.00% | 5.82% | 8.09% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
0.00 | 2.10 | 0.00 | 0.08 | 0.11 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
0.00 | 0.00 | 0.22 | 0.15 | 0.06 | 0.00 | 0.00 | 0.01 | 0.04 |
Operating CF/Net income |
0.72 | 0.89 | (1.73) | 1.70 | 0.90 | 0.92 | 0.83 | 0.72 | 0.67 |
Capex/Depreciation |
(3.51) | (0.67) | (1.31) | (5.82) | (1.05) | (2.17) | (2.21) | (10.04) | (0.14) |
Interest Coverage |
— | — | (11.59) | (27.72) | (109.99) | (61.39) | — | — | — |
| 54.58% | 51.70% | (32.23%) | (14.73%) | (52.39%) | (365.06%) | (229.04%) | (50.61%) | (110.70%) | |
| (90.85%) | (86.06%) | (14.79%) | (10.87%) | (37.63%) | (44.80%) | (54.96%) | (37.32%) | (69.03%) | |
ROIC |
(35.44%) | (14.24%) | 0.00% | 0.00% | (347.42%) | (384.74%) | (1,404.78%) | (167.38%) | 0.00% |
Return on Tangible Assets |
(115.91%) | (47.12%) | (11.62%) | (12.89%) | (65.73%) | (99.63%) | (48.06%) | (57.93%) | (149.19%) |
Average Days of Receivables |
— | 0.00 | 10.15 | 3.36 | 3.74 | 0.00 | — | 272.58 | 55.33 |
Research and Development Expense of Revenue |
0.00% | 0.00% | 64.89% | 101.17% | 433.06% | 0.00% | 0.00% | 2,802.11% | 1,025.89% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 51.26% | 73.33% | 264.26% | 0.00% | 0.00% | 1,345.00% | 440.54% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
0.00% | 0.00% | 12.47% | 26.99% | 154.61% | 0.00% | 0.00% | 196.48% | 119.76% |
Graham Net Nets |
— | — | 1.09 | 0.13 | 0.46 | — | — | 0.19 | 0.27 |
Graham Number |
— | — | 0.00 | 0.00 | 0.00 | — | — | 0.00 | 0.00 |
Earnings Yield |
— | — | (43.18%) | (2.30%) | (48.15%) | — | — | (24.67%) | (155.68%) |
Free Cash Flow Yield |
— | — | 21.86% | (4.56%) | (44.82%) | — | — | (22.96%) | (105.08%) |
Revenue per Share |
0.00 | 0.00 | 167.32 | 57.33 | 20.48 | 0.00 | 0.00 | 0.25 | 0.68 |
Operating CF per Share |
(1,036.45) | (556.34) | 197.78 | (70.05) | (110.71) | (210.37) | (44.00) | (6.73) | (8.36) |
Capex per Share |
(132.13) | (14.25) | (6.15) | (10.34) | (4.24) | (20.14) | (5.12) | (2.01) | (0.06) |
Free Cash Flow per Share |
(1,168.58) | (570.59) | 191.63 | (80.39) | (114.95) | (230.51) | (49.13) | (8.74) | (8.42) |
Cash per Share |
1,272.13 | 1,378.73 | 1,256.39 | 341.56 | 190.26 | 216.66 | 108.67 | 14.13 | 8.00 |
Shareholders Equity per Share |
0.00 | 1,321.11 | 967.39 | 298.39 | 190.43 | 254.24 | 111.13 | 17.98 | 5.48 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.00 | 1,321.11 | 967.39 | 298.39 | 190.43 | 254.24 | 111.13 | 17.98 | 5.48 |
Free Cash Flow |
(16.48) | (17.46) | 33.15 | (51.86) | (78.97) | (58.78) | (75.12) | (77.98) | (79.08) |
Working Capital |
15.73 | 39.16 | 168.58 | 198.43 | 123.32 | 48.38 | 153.25 | 116.57 | 70.44 |
Capital Expenditures |
(1.86) | (0.44) | (1.06) | (6.67) | (2.91) | (5.14) | (7.84) | (17.90) | (0.52) |
Net Current Asset Value |
17.96 | 38.82 | 165.50 | 152.83 | 80.21 | 48.17 | 120.98 | 65.71 | 20.31 |
EV/EBIT |
— | — | 3.18 | 0.00 | 0.00 | — | — | 0.00 | 0.00 |
Capex to Sales |
0.00 | 0.00 | 0.04 | 0.18 | 0.21 | 0.00 | 0.00 | 7.88 | 0.08 |
Price to Operating Income |
— | — | 0.00 | 0.00 | 0.00 | — | — | 0.00 | 0.00 |
| Other line items | |||||||||
Depreciation/Fixed assets |
0.31 | 0.43 | 0.46 | 0.16 | 0.50 | 0.24 | 0.23 | 0.06 | 0.46 |
Cash ROIC |
(25.49%) | (10.42%) | 8.62% | (12.11%) | (28.56%) | (48.95%) | (22.35%) | (27.22%) | (62.47%) |
Accounts Receivable Turnover |
— | 0.00 | 59.93 | 64.60 | 58.13 | 0.00 | — | 2.12 | 4.80 |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Average Receivables |
— | 0.48 | 0.48 | 0.57 | 0.24 | 0.30 | — | 1.07 | 1.33 |
Average Payables |
1.43 | 1.43 | 1.54 | 3.36 | 4.13 | 2.68 | 4.94 | 5.64 | 2.82 |
Average Assets |
22.27 | 22.27 | 133.88 | 243.97 | 225.04 | 129.55 | 147.70 | 223.95 | 169.87 |
Average Common Equity |
(37.08) | (37.08) | 61.42 | 179.92 | 161.66 | 15.90 | 35.44 | 165.16 | 105.93 |
Columns are period end dates